| COVID-19 |
1 |
1 |
| Food and Drug Administration (FDA) |
0 |
0.9 |
| Revenue and Practice Management |
0 |
0.75 |
| Vaccines |
0 |
0.95 |
| Drug Costs |
0 |
0.1 |
| Drug Development |
0 |
0.1 |
| Health Care Quality, Access, and Evaluation |
0 |
0.1 |
| Jobs |
0 |
0.1 |
| Nonprofit Organizations |
0 |
0.1 |
| Severe Acute Respiratory Syndrome (SARS) |
0 |
0.1 |
| Transplantation |
0 |
0.1 |
| Acute Respiratory Distress Syndrome |
0 |
0.09 |
| Antibiotics |
0 |
0.09 |
| Cosmetic Dermatology |
0 |
0.09 |
| Multiple Sclerosis |
0 |
0.09 |
| Social Determinants of Health |
0 |
0.09 |
| Type 2 Diabetes Mellitus |
0 |
0.09 |